Posts

Revolutionary AI Tool Set to Transform Forensic Investi...

A groundbreaking collaboration between a diverse group of esteemed institutions,...

Tardigrade Protein Shows Promise in Enhancing Radiation...

In the landscape of cancer treatment, radiation therapy stands as a cornerstone,...

Roche Comes Out With Novel ‘Sequencing-By-Expansion’ Ap...

Roche has proposed a fresh kind of genetic analysis. This process, which the com...

MeiraGTx Gene Therapy Shows Promise in Restoring Vision...

Eleven children who were born legally blind experienced significant improvements...

6yMirum’s Ctexli surpasses FDA milestone for rare metab...

After Mirum Pharmaceuticals spent $210 million to acquire Travere Therapeutics’ ...

Eli Lilly Lowers Zepbound Prices and Expands Dosage Opt...

Eli Lilly has announced a reduction in the price of vials for its obesity medica...

MeiraGTx seeks UK approval after gene therapy restores ...

MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 c...

Teva and Alvotech launch ustekinumab biosimilar injecti...

Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (uste...

FDA approves Mirum’s Ctexli for cerebrotendinous xantho...

Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administra...

FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorecta...

The FDA has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence...

Pfizer sets sights on Summit’s bispecific in combo with...

Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summ...

EC authorises Celltrion’s Avtozma for multiple indications

Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimi...

Transforming manufacturing and packaging at PHARMAP 2025

PHARMAP 2025 takes place on 14-15 April 2025 in Berlin, Germany.

Semaglutide shortage ends as FDA sets deadline for comp...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat ...

Sionna Therapeutics’ IPO: A strategic shift in the cyst...

Sionna Therapeutics recently secured an initial public offering (IPO) of $191m o...

Melatonin Supplementation May Mitigate DNA Damage Assoc...

Melatonin, a hormone primarily known for regulating sleep cycles, has emerged as...